At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
F&P Full-Face Maskdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of a Full-Face Mask for the Treatment of Obstructive Sleep Apnea (OSA)
In Brief
A clinical study evaluating F&P Full-Face Mask for Obstructive Sleep Apnea. Completed, enrolled 44 participants across 1 site.
Detailed Summary
The investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartNov 2017
First PostedNov 2017
Primary CompletionJul 2018
TodayJul 2026
First PostedNov 6, 2017
Enrollment StartNov 3, 2017
Primary CompletionJul 31, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 8.7 years ago
Interventions
F&P Full-Face Maskdevice
The F\&P full-face mask will serve as the participant's primary PAP therapy mask for the duration of the trial period (from Visit 2 to Visit 3). For participants taking part in the study extension, they will be using the trial full-face mask as their primary PAP therapy mask for 6 months after Visit 3.